Press Releases

Printer Friendly Version Print Page  |E-mail this page E-mail Page  |E-mail Alerts E-mail Alerts  |View contacts IR Contacts

DateTitle 
07/02/15OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned AcquisitionPrinter Friendly Version
06/08/15Bio-Reference Laboratories, Inc. Reports Solid Revenues and Earnings for Q2FY15Printer Friendly Version
06/08/15OPKO and Bio-Reference Laboratories To Hold Joint Conference Call to Discuss MergerPrinter Friendly Version
06/04/15OPKO Health to Acquire Bio-Reference LaboratoriesPrinter Friendly Version
06/01/15BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2015Printer Friendly Version
04/14/15BioReference Laboratories Partners With Organizations Accelerating Medical InnovationPrinter Friendly Version
03/05/15Bio-Reference Laboratories, Inc. Reports Over 15% Increase in Revenue; Net Income Up Over 100%, Year Over YearPrinter Friendly Version
02/26/15BioReference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2015Printer Friendly Version
02/25/15BioReference Laboratories, Inc. Launches OnkoSight(TM), an Advanced Tumor Sequencing ProgramPrinter Friendly Version
02/12/15BioReference Laboratories, Inc. Hires Industry Veteran, Joseph F. Donahue, to Lead New Business GroupPrinter Friendly Version
12/18/14BioReference Laboratories, Inc. Announces Quarterly and Yearly Record Revenues, Net Income and Patient VolumesPrinter Friendly Version
12/11/14BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2014Printer Friendly Version
08/27/14BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Third Quarter FY2014Printer Friendly Version
08/20/14BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2014Printer Friendly Version
06/05/14BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Second Quarter FY2014Printer Friendly Version
05/29/14BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2014Printer Friendly Version
04/16/14Bio-Reference Laboratories, Inc. Announces That Robert Daber, Ph.D. Will Join Company as Director of R&D and Cancer GeneticsPrinter Friendly Version
03/04/14Bio-Reference Laboratories, Inc. Reports Revenue Growth Despite Reimbursement Pressure and Impactful WeatherPrinter Friendly Version
02/25/14BioReference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2014Printer Friendly Version
12/19/13Bio-Reference Laboratories, Inc. Announces Record Quarterly Revenues and Record Annual Revenues and Earnings Despite Significant 4th Quarter HeadwindsPrinter Friendly Version
12/12/13BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2013Printer Friendly Version
11/27/13BioReference Laboratories, Inc. Provides Guidance for FY13 and Q4FY13 Anticipated ResultsPrinter Friendly Version
10/22/13BioReference Laboratories, Inc. Sued by Myriad Genetics, Confident in Its PositionPrinter Friendly Version
08/29/13BioReference Laboratories, Inc. Reports Sustained Growth on Strong Quarterly ResultsPrinter Friendly Version
08/22/13BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2013Printer Friendly Version
08/21/13BioReference Laboratories, Inc. Announces Strategic Acquisition of Edge BioSystems' Service BusinessPrinter Friendly Version
08/13/13BioReference Laboratories, Inc. Announces Strategic AcquisitionPrinter Friendly Version
08/08/13Bio-Reference Laboratories and Coastal VIM Clinic Partner to Provide Free Clinical Tests to PatientsPrinter Friendly Version
07/22/13Bio-Reference to License GeneTests.org from University of WashingtonPrinter Friendly Version
06/13/13GeneDx to Launch Comprehensive Breast Cancer Genetic TestPrinter Friendly Version
06/06/13UPDATE -- BioReference Laboratories, Inc. Reports Record Quarterly Results Based on Sustained GrowthPrinter Friendly Version
06/06/13BioReference Laboratories, Inc. Reports Record Quarterly Results Based on Sustained GrowthPrinter Friendly Version
06/05/13Bio-Reference Laboratories, Inc to Speak at William Blair & Company's 33rd Annual Growth Stock ConferencePrinter Friendly Version
05/30/13Bio-Reference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2013Printer Friendly Version
05/15/13BioReference Laboratories, Inc to Speak at the UBS Global Healthcare ConferencePrinter Friendly Version
05/08/13Bio-Reference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care ConferencePrinter Friendly Version
04/12/13Bio-Reference Laboratories, Inc. Responds to an Employee Wrongful Termination Suit Filed Against it as Baseless and Without MeritPrinter Friendly Version
02/28/13Bio-Reference Laboratories, Inc. Announces Strong Growth Resulting in Record First Quarter Revenue and EarningsPrinter Friendly Version
02/27/13Bio-Reference Laboratories, Inc. Will Offer Non-Invasive Prenatal Testing (NIPT) From NateraPrinter Friendly Version
02/25/13Bio-Reference Laboratories, Inc. Announces Earnings Will be Reported on February 28, 2013, Will Reflect Change in Presentation of Revenues and Bad Debt to Comply With Accounting Standards Update Topic 954; No Effect on Net Income or EPS From Update ImplementationPrinter Friendly Version
12/18/12Bergen County-based Bio-Reference Donates $100,000 to Hurricane Sandy New Jersey Relief FundPrinter Friendly Version
12/06/12Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and for Full Fiscal Year Despite Effects of Hurricane SandyPrinter Friendly Version
12/05/12BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2012Printer Friendly Version
10/10/12Bio-Reference to Launch Laboratorio Buena Salud, The First Nationwide Full-Service Hispanic LaboratoryPrinter Friendly Version
08/30/12Bio-Reference Laboratories, Inc. Reports Best Quarterly Revenues and Earnings in Corporate History with 25% Increase in Earnings Per SharePrinter Friendly Version
08/23/12BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2012Printer Friendly Version
06/26/12GenPath Diagnostics of BioReference Laboratories, Inc. Awarded 2012 Clinical Diagnostics Company of the Year Award by Frost & SullivanPrinter Friendly Version
06/07/12Bio-Reference Laboratories, Inc. Reports Strong Quarterly ResultsPrinter Friendly Version
05/31/12BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2012Printer Friendly Version
04/30/12BRLI Announces InCellDx Investment and Launch of GenCerv Test Through its GenPath Women’s Health LaboratoryPrinter Friendly Version
03/01/12Bio-Reference Laboratories, Inc. Announces Record First Quarter Revenue, Earnings and Cash Flow from OperationsPrinter Friendly Version
02/23/12Bio-Reference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2012Printer Friendly Version
02/08/12BioReference Announces 2012 Annual Meeting DatePrinter Friendly Version
01/26/12BioReference to Launch Groundbreaking Solid Tumor Genotyping Test through its GenPath Oncology LaboratoryPrinter Friendly Version
01/12/12BioReference Laboratories, Inc. Announces Contract with Corizon, Inc. to Provide Correctional Healthcare Laboratory ServicesPrinter Friendly Version
12/08/11Bio-Reference Laboratories, Inc. Announces Record Revenues, Earnings and Cash Flow for Fourth Quarter and Full Fiscal YearPrinter Friendly Version
12/07/11BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2011Printer Friendly Version
12/07/11BioReference Laboratories, Inc. to Speak at the Oppenheimer 22nd Annual Healthcare ConferencePrinter Friendly Version
11/22/11Bio-Reference Laboratories, Inc. and McKesson Specialty Health's Onmark GPO Execute Purchasing AgreementPrinter Friendly Version
11/18/11Bio-Reference Laboratories' CEO Marc Grodman MD Speaks at Capitol Hill Policy Forum on the Contribution Genetic Tests Are Making to Cancer CarePrinter Friendly Version
11/15/11Bio-Reference Laboratories Named 8th Fastest Growing Company in State of New JerseyPrinter Friendly Version
11/11/11Bio-Reference Laboratories, Inc. Announces Stock Buy-Back PlanPrinter Friendly Version
11/09/11BioReference Laboratories, Inc to Speak at the Lazard Capital Markets 8th Annual Healthcare ConferencePrinter Friendly Version
10/27/11GenPath Women's Health in Collaboration with GeneDX to Launch Breakthrough in Genetic Screening for Family PlanningPrinter Friendly Version
10/12/11GeneDxUnveils Groundbreaking Test to Identify Rare Inherited DiseasesPrinter Friendly Version
09/13/11BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences ConferencePrinter Friendly Version
08/25/11Bio-Reference Laboratories, Inc. Reports 26% increase in Net Income, 22% increase in Net Revenue, 20% increase in Patient CountPrinter Friendly Version
08/18/11BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter, Fiscal Year 2011Printer Friendly Version
06/08/11BioReference Laboratories, Inc to Speak at William Blair & Company's 31st Annual Growth Stock ConferencePrinter Friendly Version
05/31/11BioReference Laboratories, Inc. to Speak at the 2011 Jefferies Global Healthcare ConferencePrinter Friendly Version
05/26/11CORRECTING and REPLACING Bio-Reference Laboratories, Inc. Reports Record Quarterly SuccessPrinter Friendly Version
05/26/11Bio-Reference Laboratories, Inc. Reports Record Quarterly SuccessPrinter Friendly Version
05/19/11BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2011Printer Friendly Version
05/03/11BioReference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care ConferencePrinter Friendly Version
03/03/11BioReference Laboratories, Inc. Reports 23% Revenue, 20% Patient Count Increase in Solid Quarterly ResultsPrinter Friendly Version
02/24/11BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2011Printer Friendly Version
12/16/10Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and Fiscal YearPrinter Friendly Version
12/09/10BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2010Printer Friendly Version
11/30/10Bio-Reference Laboratories, Inc. Announces Massachusetts General Hospital Agreement for CollaborationPrinter Friendly Version
11/10/10BioReference Laboratories, Inc. to Speak at the Lazard Capital Markets 7th Annual Healthcare ConferencePrinter Friendly Version
09/13/10BioReference Laboratories, Inc. to Speak at the UBS Global Life Sciences ConferencePrinter Friendly Version
08/26/10Bio-Reference Laboratories, Inc. Announces 25% Revenue Growth, 17% Patient Growth, Record IncomePrinter Friendly Version
08/19/10BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2010Printer Friendly Version
05/27/10Bio-Reference Laboratories, Inc. Reports Record Quarterly RevenuesPrinter Friendly Version
05/20/10BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2010Printer Friendly Version
05/04/10BioReference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care ConferencePrinter Friendly Version
04/07/10BioReference Laboratories, Inc. Announces 2 for 1 Stock SplitPrinter Friendly Version
03/04/10BioReference Laboratories, Inc. Reports Sustained Growth from All Business Units in the First QuarterPrinter Friendly Version
02/25/10BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2010Printer Friendly Version
02/01/10BioReference Laboratories, Inc to Speak at the UBS 20th Annual Global Healthcare Services ConferencePrinter Friendly Version
01/19/10BioReference Laboratories, Inc to Speak at theJefferies 2010 Global Healthcare Services ConferencePrinter Friendly Version
12/17/09Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and Fiscal YearPrinter Friendly Version
12/10/09BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2009Printer Friendly Version
11/05/09Bio-Reference Laboratories, Inc. Again Awarded New York State Department of Corrections Laboratory Services ContractPrinter Friendly Version
10/27/09BioReference Laboratories, Inc to Speak at the Oppenheimer 20th Annual Health Care ConferencePrinter Friendly Version
09/14/09BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/02/09Bio-Reference Laboratories, Inc. Announces Continued Strong Growth Across All Laboratory DivisionsPrinter Friendly Version
08/26/09BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2009Printer Friendly Version
06/12/09BioReference Laboratories, Inc. to Speak at the Jefferies 3rd Annual Healthcare ConferencePrinter Friendly Version
06/05/09BioReference Laboratories, Inc to speak at the William Blair 29th Annual Growth Stock ConferencePrinter Friendly Version
06/04/09Bio-Reference Laboratories, Inc. Reports Record Quarterly RevenuesPrinter Friendly Version
05/28/09BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2009Printer Friendly Version
05/06/09BioReference Laboratories, Inc. to speak at the Bank of America and Merrill Lynch 2009 Health Care ConferencePrinter Friendly Version
04/07/09BioReference Laboratories, Inc. Announces NextGen Sequencing for Dilated Cardiomyopathy (DCM) TestingPrinter Friendly Version
03/05/09BioReference Laboratories, Inc. Reports Continued Growth in the First Quarter Led by Esoteric TestingPrinter Friendly Version
02/26/09BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2009Printer Friendly Version
02/03/09BioReference Laboratories, Inc to Speak at The UBS Global Healthcare Services ConferencePrinter Friendly Version
01/26/09Bio-Reference Laboratories, Inc. Announces Restitution Agreement with Former EmployeePrinter Friendly Version
12/18/08Bio-Reference Laboratories, Inc. Announces Record-Breaking Year-End and Fourth Quarter ResultsPrinter Friendly Version
12/11/08BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2008Printer Friendly Version
11/06/08BioReference Laboratories, Inc to Speak at the 2008 Credit Suisse Phoenix Health Care ConferencePrinter Friendly Version
10/28/08BioReference Laboratories, Inc to Speak at the Oppenheimer 19th Annual Health Care ConferencePrinter Friendly Version
09/19/08BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/04/08Bio-Reference Laboratories, Inc. Announces Continued Strong Growth Led by Solid Gains in Its Esoteric Testing DivisionsPrinter Friendly Version
08/28/08BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2008Printer Friendly Version
08/06/08Bio-Reference Laboratories, Inc. Announces K-ras Testing Availability Through GenPathPrinter Friendly Version
07/14/08Bio-Reference Laboratories, Inc. Announces Stock Buy-Back PlanPrinter Friendly Version
06/17/08BioReference Laboratories, Inc to Speak at the Jefferies Healthcare ConferencePrinter Friendly Version
06/13/08BioReference Laboratories, Inc. to Speak at the William Blair Annual Growth Stock ConferencePrinter Friendly Version
06/05/08Bio-Reference Laboratories, Inc. Reports Continued Sustained Growth on Record Quarterly RevenuesPrinter Friendly Version
05/29/08BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2008Printer Friendly Version
05/07/08BioReference Laboratories, Inc. to Speak at the Bank of America Securities HealthCare ConferencePrinter Friendly Version
03/13/08BioReference Laboratories, Inc to Speak at the Eleventh Annual Lehman Brothers Global Healthcare ConferencePrinter Friendly Version
03/06/08BioReference Laboratories, Inc. Reports 24% Increase in Revenues, Sees Continued Growth in All Market SegmentsPrinter Friendly Version
02/28/08BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2008Printer Friendly Version
02/06/08BioReference Laboratories, Inc. to Speak at the UBS Global Healthcare Services ConferencePrinter Friendly Version
01/03/08BioReference Laboratories, Inc. to Speak at the JPMorgan Healthcare ConferencePrinter Friendly Version
12/20/07Bio-Reference Laboratories, Inc. Announces Record-Breaking Year-End and Fourth Quarter ResultsPrinter Friendly Version
12/18/07BioReference Laboratories and PVT Announce Agreement to Install PVT Equipment at BioReferencePrinter Friendly Version
12/13/07BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2007Printer Friendly Version
10/02/07BioReference Laboratories, Inc. to Speak at the William Blair Small-Cap Growth Stock ConferencePrinter Friendly Version
09/21/07BioReference Laboratories, Inc. to Speak at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/07/07BioReference Laboratories, Inc to Speak at the Credit Suisse HOLT: Under Followed Opportunities ConferencePrinter Friendly Version
09/07/07BioReference Laboratories, Inc to Speak at the Bear Sterns 20th Annual Healthcare ConferencePrinter Friendly Version
09/06/07BioReference Laboratories, Inc. Announces 35% Increase in Net Revenues, 50% Increase in Operating Income, Year Over YearPrinter Friendly Version
08/30/07BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2007Printer Friendly Version
06/20/07BioReference Laboratories, Inc. to Speak at the Jefferies Healthcare ConferencePrinter Friendly Version
06/07/07Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly RevenuesPrinter Friendly Version
05/31/07BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2007Printer Friendly Version
05/24/07BioReference Laboratories, Inc. to Speak at the Bank of America Securities Healthcare ConferencePrinter Friendly Version
03/08/07BIOREFERENCE LABORATORIES, INC. REPORTS 25% INCREASE IN REVENUES, STRONG INCREASE IN OPERATING INCOME AND AFTER TAX NET INCOME ON A Q OVER Q BASIS FOR Q1FY07Printer Friendly Version
03/01/07BIOREFERENCE LABORATORIES, INC. ANNOUNCES EARNINGS DATE FOR FIRST QUARTER FOR FISCAL YEAR 2007Printer Friendly Version
02/28/07BIOREFERENCE LABORATORIES ANNOUNCES NEW HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY ANCILLARY SERVICES ARRANGEMENT Printer Friendly Version
02/23/07BIOREFERENCE LABORATORIES, INC TO SPEAK AT THE SUSQUEHANNA SIGNIFICANT INVESTMENT OPTIONS IN HEALTHCARE CONFERENCEPrinter Friendly Version
02/05/07BIOREFERENCE LABORATORIES, INC TO SPEAK AT THE UBS GLOBAL HEALTHCARE SERVICES CONFERENCEPrinter Friendly Version
01/22/07BIOREFERENCE LABORATORIES REPORTS HORIZON BLUE CROSS BLUE SHIELD ANCILLARY SERVICES AGREEMENT TERMINATION; LABORATORY INTENDS TO CONTEST TERMINATIONPrinter Friendly Version
01/03/07BIOREFERENCE LABORATORIES, INC TO SPEAK AT THE JPMORGAN HEALTHCARE CONFERENCEPrinter Friendly Version
12/19/06BIOREFERENCE LABORATORIES, INC. ANNOUNCES RECORD-BREAKING YEAR-END AND FOURTH QUARTER RESULTSPrinter Friendly Version
12/14/06BIOREFERENCE LABORATORIES ANNOUNCES AETNA NATIONAL ANCILLARY SERVICES AGREEMENT EFFECTIVE DECEMBER 15, 2006Printer Friendly Version
12/13/06BIOREFERENCE LABORATORIES TO RING THE NASDAQ STOCK MARKET CLOSING BELL IN NEW YORKPrinter Friendly Version
12/12/06Bio-Reference Laboratories, Inc. Announces Earnings Date for the Fiscal Year 2006Printer Friendly Version
12/01/06BIOREFERENCE LABORATORIES ANNOUNCES AETNA NATIONAL ANCILLARY SERVICES AGREEMENT EFFECTIVE DECEMBER 15, 2006Printer Friendly Version
10/03/06Bio-Reference Laboratories Announces Extension of Provider Participation Agreement with United Healthcare to Include Oxford Health Plans Effective January 2007Printer Friendly Version
09/22/06Bio-Reference Laboratories, Inc to Speak at the Noble Financial Group OnTrack Equity ConferencePrinter Friendly Version
09/21/06Bio-Reference Laboratories, Inc. to Speak at the UBS Global Life Sciences ConferencePrinter Friendly Version
08/29/06Bio-Reference Laboratories, Inc. Announces Agreement to Acquire Gene-Based Testing Laboratory, Third Quarter Results and Reaffirms Guidance for Year; Company Signals Major Initiative into Gene-Based Testing by Acquiring GeneDxPrinter Friendly Version
06/08/06Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues; Company Reports 18% Increase in Net Revenues and 93% Increase in Fully Taxed Net Income in Q2 Comparisons of FY06 to FY05Printer Friendly Version
06/01/06Bio-Reference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2006Printer Friendly Version
05/12/06Bio-Reference Laboratories, Inc. to Speak at the Banc of America Securities HealthCare ConferencePrinter Friendly Version
03/09/06Bio-Reference Laboratories, Inc. Posts 25% Increase in Q1 After-Tax Net Income Based on 17% Increase in Year over Year Revenues; Company Reports a 21% Increase in Operating Income for the Quarter over the Prior Year Same QuarterPrinter Friendly Version
03/02/06Bio-Reference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2006Printer Friendly Version
01/05/06BioReference Laboratories, Inc. Announces Record Annual Revenues and Record Revenues and Operating Income for Q4FY05; Operating income for Q4FY05 tops Q4FY04 by 16%Printer Friendly Version
01/04/06Bio-Reference Introduces New Lab Procedure to Identify and Detect Early Onset of Prostate Cancer; Bio-Reference Finds Some High-Risk Patients with Normal PSA Results May Be at Risk for Prostate CancerPrinter Friendly Version
12/29/05Bio-Reference Laboratories, Inc. Announces Earnings Date for the Fiscal Year 2005Printer Friendly Version
12/02/05Bio-Reference CEO, Marc Grodman, M.D., to Speak on Pay-for-Performance; Dr. Grodman Will Present in a Washington G-2 Audio Conference on Wednesday, December 7thPrinter Friendly Version
11/03/05Bio-Reference Laboratories, Inc to Speak at the Noble Financial Group Small Cap ConferencePrinter Friendly Version
09/20/05Bio-Reference Laboratories, Inc. to Speak at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/07/05Bio-Reference Laboratories, Inc. Announces Best Ever Revenues on Positive Year over Year Operating Income and EPS; Third Quarter Revenues Increase over 19% and Nine Month Revenues Increase Nearly 22% on a Year over Year ComparisonPrinter Friendly Version
08/31/05Bio-Reference Laboratories, Inc. Announces Earnings Date for the Third Quarter of Fiscal 2005Printer Friendly Version
08/23/05Bio-Reference Laboratories, Inc. Announces PSIMedica Contract with Keenan & Associates, Inc.Printer Friendly Version
06/22/05Bio-Reference Laboratories, Inc. Announces Contract with Correctional Medical ServicesPrinter Friendly Version
06/02/05Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues; Company Reports 19% Increase for Q2 and 23% Increase in Net Revenues for First 6 Months of FY05; Announces Stock Buy Back PlanPrinter Friendly Version
05/26/05Bio-Reference Laboratories, Inc. Announces Earnings Date for the Second Quarter of Fiscal 2005Printer Friendly Version
05/12/05Bio-Reference Laboratories, Inc. to Speak at the Banc of America Securities HealthCare ConferencePrinter Friendly Version
04/28/05Bio-Reference Laboratories Announces CareEvolve Selection by HealthvisionPrinter Friendly Version
03/03/05Bio-Reference Laboratories, Inc. Records 27% Increase in Q1 Net Revenues, Expands Infrastructure to Meet National DemandsPrinter Friendly Version
02/25/05Bio-Reference Laboratories Announces Strategic Alliance with BD and Introduction of GenFlowPrinter Friendly Version
02/24/05Bio-Reference Laboratories, Inc. Announces Earnings Date for the First Quarter of Fiscal 2005Printer Friendly Version
02/11/05Bio-Reference Laboratories, Inc to Speak at the UBS Global Healthcare Services ConferencePrinter Friendly Version
01/06/05Bio-Reference Laboratories, Inc. Announces Record Results Across the Board for Q4 and All of FY2004Printer Friendly Version
12/28/04Bio-Reference Laboratories, Inc. Announces Earnings Date for the Fiscal Year 2004Printer Friendly Version
12/07/04Bio-Reference Laboratories, Inc. Announces Agreement with The Segal Company to Provide PSIMedica Analytical ServicesPrinter Friendly Version
10/20/04Bio-Reference Laboratories, Inc. Named to the 2004 Forbes List of the 200 Best Small CompaniesPrinter Friendly Version
09/24/04Bio-Reference Laboratories, Inc to Speak at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/09/04Bio-Reference Laboratories, Inc. Announces 24% Increase in Quarterly Revenues, Best Ever Revenues and EarningsPrinter Friendly Version
09/07/04Bio-Reference Laboratories, Inc. Announces Earnings Date for the Third Quarter of Fiscal 2004Printer Friendly Version
07/12/04Bio-Reference Laboratories, Inc. Acquires Molecular and Cytogenetics LaboratoryPrinter Friendly Version
07/07/04Bio-Reference Laboratories, Inc. Announces Indiana Correctional Healthcare ContractPrinter Friendly Version
06/30/04Bio-Reference Laboratories, Inc. Added to Russell 3000 IndexPrinter Friendly Version
06/29/04Bio-Reference Laboratories, Inc. Named to the Fortune Small Business Latest 100 Fastest Growing Small CompaniesPrinter Friendly Version
06/17/04Bio-Reference Laboratories, Inc. Announces Kansas Correctional Healthcare ContractPrinter Friendly Version
06/03/04Bio-Reference Laboratories, Inc. Records Best Ever Earnings on 30% Quarterly Revenue IncreasePrinter Friendly Version
06/02/04CORRECTING and REPLACING Bio-Reference Laboratories, Inc. Announces PSIMedica Contract with Lockton Companies, Inc. to Control Health Care CostsPrinter Friendly Version
06/02/04Bio-Reference Laboratories, Inc. Announces PSIMedica Contract with Lockton Companies to Control Health Care CostsPrinter Friendly Version
06/01/04Bio-Reference Laboratories, Inc. Named to BusinessWeek's Latest 100 Top Hot Growth Stocks ListPrinter Friendly Version
05/27/04Bio-Reference Laboratories, Inc. Announces Earnings Date for the Second Quarter of Fiscal 2004Printer Friendly Version
05/12/04Bio-Reference Laboratories, Inc. to Speak at the Banc of America Securities HealthCare ConferencePrinter Friendly Version
03/30/04Bio-Reference Laboratories, Inc. Announces New 5 Year Contract with NY State Department of CorrectionsPrinter Friendly Version
03/04/04Bio-Reference Laboratories, Inc. Records Best Ever First Quarter Revenues and Net IncomePrinter Friendly Version
02/26/04Bio-Reference Laboratories, Inc. Announces Earnings Date for the First Quarter of Fiscal 2004Printer Friendly Version
02/11/04Bio-Reference Laboratories, Inc. Announces Board of Directors ChangesPrinter Friendly Version
01/27/04Bio-Reference Laboratories, Inc. Announces That IMPATH INC. Has Started Suit Against One Of Its EmployeesPrinter Friendly Version
01/22/04Bio-Reference Laboratories Announces Collaboration Agreement with Sysmex America to Further Advance Hematology DiagnosticsPrinter Friendly Version
01/08/04Bio-Reference Laboratories, Inc. Announces Record Operating Results For Q4 And All Of FY2003, Including Significant Gains in Net Revenues, Earnings and Net IncomePrinter Friendly Version
12/30/03Bio-Reference Laboratories, Inc. Announces Earnings Date for Fiscal Year 2003Printer Friendly Version
10/23/03Bio-Reference Laboratories Names Scientific Advisory Board MembersPrinter Friendly Version
09/25/03Bio-Reference Laboratories Names James Weisberger, M.D. To Medical StaffPrinter Friendly Version
09/18/03Bio-Reference Laboratories, Inc. Announces That BioView DUET, a Cancer Diagnostic System, Has Received FDA ApprovalPrinter Friendly Version
09/16/03Bio-Reference Laboratories, Inc. Awarded Statewide Pennsylvania Prison Lab ContractPrinter Friendly Version
09/04/03Bio-Reference Laboratories, Inc. Announces Substantial Gains on Record Operating Results, Including a 53% Increase in Taxed Net Income on a 16% Increase in Net RevenuesPrinter Friendly Version
08/28/03Bio-Reference Laboratories, Inc. Announces Earnings Date For The Third Quarter Of Fiscal 2003Printer Friendly Version
08/21/03Bio-Reference Laboratories Names John M. Bennett, MD, Noted Leukemia/Lymphoma Authority, to Head Scientific Advisory BoardPrinter Friendly Version
08/20/03Bio-Reference's CareEvolve Subsidiary Executes New Contracts, Wins AwardPrinter Friendly Version
07/01/03Bio-Reference Laboratories, Inc. Awarded Spot on Fortune SB 'America's Fastest-Growing Small Public Companies' ListPrinter Friendly Version
06/18/03Bio-Reference Laboratories, Inc. to Speak at the Morgan Keegan & Company, Inc. Healthcare ConferencePrinter Friendly Version
06/05/03Bio-Reference Laboratories, Inc. Reports Record Revenues, Record Net Income Despite Adverse ConditionsPrinter Friendly Version
05/21/03Bio-Reference Laboratories, Inc. Announces Earnings Date for the Second Quarter of Fiscal 2003Printer Friendly Version
04/23/03Bio-Reference Laboratories Executes Strategic Marketing Agreement with BIOVIEW, Inc. for the Enhanced Molecular Diagnosis Of CancerPrinter Friendly Version
04/03/03Bio-Reference Laboratories CEO, Marc Grodman M.D., to Speak at the Wachovia Securities Cancer Diagnostics ConferencePrinter Friendly Version
03/06/03Bio-Reference Laboratories, Inc. Announces Additional Details of Stock Buy-Back PlanPrinter Friendly Version
03/06/03Bio-Reference Laboratories, Inc. Affirms Guidance; Announces Stock Buy-Back Plan in Earnings AnnouncementPrinter Friendly Version
02/27/03Bio-Reference Laboratories, Inc. Announces Earnings Date for the First Quarter of Fiscal 2003Printer Friendly Version
01/28/03Bio-Reference Laboratories, Inc to Speak at the UBS Warburg Global Healthcare Services ConferencePrinter Friendly Version
01/21/03Bio-Reference Laboratories Awarded New York State Prison Contract for Fifth Consecutive Year; Contract Valued at Approximately $7MPrinter Friendly Version
01/09/03Bio-Reference Laboratories, Inc. Confirms Street Estimates on Conference CallPrinter Friendly Version
01/09/03Bio-Reference Laboratories, Inc. Reports 168% Increase in Pre-Tax Income and 20% Increase in Revenue for Fiscal 2002Printer Friendly Version
01/02/03Bio-Reference Laboratories, Inc. Announces Date for 2002 Year End Earnings and Conference CallPrinter Friendly Version
12/19/02Bio-Reference's CareEvolve Subsidiary Executes Contract With S.E.D. Medical LaboratoriesPrinter Friendly Version
12/12/02Bio-Reference Laboratories, Inc. Adjusts Guidance and Announces 2002 Year End Earnings Date; Company On Track with Upgraded Guidance For Fiscal 2002Printer Friendly Version